GE HealthCare acquires $945m Sofie Biosciences
Global MedTech and diagnostocs leader GE HealthCare has acquired Sofie Biosciences, a privately-held developer of radiopharmaceuticals and molecular imaging diagnostics, in a transaction valued at $945 million. The deal marks a major step forward in GE HealthCare’s strategy to expand its precision diagnostics business and secure greater operational control over the highly complex and time-sensitive radiopharmaceutical supply chain. Molecular imaging…
GE Healthcare acquires imaging software specialist Intelerad
Global medical technology, diagnostics, and digital solutions giant GE HealthCare (GEHC) has announced a strategic $2.3 billion acquisition of US-based Intelerad, a leading cloud-based medical imaging software provider. According to the group, this move directly addresses the $2 billion-plus outpatient enterprise imaging opportunity, where cloud-native solutions are projected to grow at double-digit rates due to rising outpatient procedures and demand…